ESC 365 - Efficacy and safety results of endovascular baroreflex amplification (EBA) for resistant hypertension (CALM-FIM studies): a safety and proof-of-principle cohort study.

ESC Premium Access

Efficacy and safety results of endovascular baroreflex amplification (EBA) for resistant hypertension (CALM-FIM studies): a safety and proof-of-principle cohort study.

Session: Device-based therapy for hypertension - Where next?

Topic: Devices / interventions

Speaker: Doctor W. Spiering (Utrecht, NL)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Wilko Spiering

University Medical Center Utrecht, Utrecht (Netherlands (The))

3 presentations

0 follower

4 more presentations in this session

State of the Art: device-based therapy for hypertension

Speaker: Professor M. Lobo (London, GB)

Sham or no-sham control in trials of renal denervation for treatment resistant hypertension: a systematic meta-analysis

Speaker: Doctor F. Fadl El Mula (Riyadh, SA)

Validating renal nerve stimulation-induced blood pressure changes as a predictor of clinical response to renal sympathetic denervation

Speaker: Doctor M. de Jong (Zwolle, NL)

Designing trials for devices in hypertension - What have we learned?

Speaker: Professor F. Mahfoud (Basel, CH)

Access the full session

Device-based therapy for hypertension - Where next?

Speakers: Doctor W. Spiering, Professor M. Lobo, Doctor F. Fadl El Mula, Doctor M. de Jong, Professor F. Mahfoud

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources